Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinal cell lipid membranes are specialized structures essential for the visual cycle, characterized by an exceptionally high concentration of long-chain polyunsaturated fatty acids, particularly docosahexaenoic acid (DHA) (SanGiovanni & Chew, 2005, Progress in Retinal and Eye Research). These membranes, found predominantly in photoreceptor outer segments and the retinal pigment epithelium (RPE), provide the necessary fluid environment for the rapid conformational changes of opsins during phototransduction (Bazán, 2006, Journal of Lipid Research). Beyond structural support, they facilitate critical processes such as the phagocytosis of shed photoreceptor discs and the selective transport of nutrients across the blood-retinal barrier (Sparrow et al., 2010, Physiological Reviews). In pathological states like age-related macular degeneration (AMD) and Stargardt disease, these membranes become sites of chronic oxidative damage and the accumulation of toxic lipid-derived byproducts like lipofuscin and A2E (Kaur et al., 2009, BMC Ophthalmology). Therapeutic interventions targeting these membranes typically involve antioxidant supplementation, such as lutein and zeaxanthin, to prevent lipid peroxidation or the use of membrane-stabilizing agents like elamipretide to preserve mitochondrial and cellular viability (Age-Related Eye Disease Study 2 Research Group, 2013, JAMA). Maintaining the health of these lipid bilayers is crucial for preventing the progression of degenerative retinal diseases.
The primary mechanisms of action include the neutralization of reactive oxygen species to prevent lipid peroxidation, the supplementation of polyunsaturated fatty acids to maintain membrane fluidity and structural integrity, and the stabilization of mitochondrial membranes to prevent apoptosis and metabolic dysfunction.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal cell lipid membrane.